3rd Quarter - Report — STARBUCKS CORPORATION for STARBUCKS CORPORATION (2011)

Firm

STARBUCKS CORPORATION

Client

STARBUCKS CORPORATION

Income

—

Expenses

$110,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Banking BAN

Public Law 111-203 - Dodd-Frank Wall Street Reform and Consumer Protection Act; financial reform related to interchange.

Lobbyist	Covered position, as disclosed
LORI OTTO PUNKE	—

Contacted: White House Office; SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Treasury, Dept of

Taxation/Internal Revenue Code TAX

Tax proposals regarding the treatment of foreign income, including advocating for a proposal to expand the active royalties exception (no specific bill number).

Lobbyist	Covered position, as disclosed
LORI OTTO PUNKE	—

Contacted: Food & Drug Administration (FDA); White House Office; SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Treasury, Dept of; U.S. Trade Representative (USTR)

Health care and health care technology issues including A) Implementation of PL 111-148 - Patent Protection and Affordable Care Act (PPACA); B) implementation of menu labeling requirements; and C) development of health information technologies and their relationship to self-funded health benefit plans (no specific bill number).

Lobbyist	Covered position, as disclosed
LORI OTTO PUNKE	—

Contacted: HOUSE OF REPRESENTATIVES; Treasury, Dept of; SENATE; White House Office; U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Food Industry (safety, labeling, etc.) FOO

PL 111-148 - Patent Protection and Affordable Care Act (PPACA) with respect to implementation of menu labeling requirements. Issues relating to FDA sodium reduction efforts (no specific bill).

Lobbyist	Covered position, as disclosed
LORI OTTO PUNKE	—

Contacted: Health & Human Services, Dept of (HHS); White House Office; Treasury, Dept of; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; U.S. Trade Representative (USTR)

Trade (domestic/foreign) TRD

Seek the reduction of import duties (and other non-tariff barriers to trade) related to the U.S. Panama Free Trade Agreement (FTA), Colombia FTA, and Korea FTA.

Lobbyist	Covered position, as disclosed
LORI OTTO PUNKE	—

Contacted: SENATE; U.S. Trade Representative (USTR); Food & Drug Administration (FDA); Treasury, Dept of; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; White House Office

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.